Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients with Chest Wall Breast Cancer (PERICLES): an immune-biomarker analysis of tumor infiltrating lymphocytes (TILs) and programmed cell death ligand protein 1 (PD-L1)

被引：1
|
作者：
Valenza, Carmine
Giachetti, Pier Paolo Maria Berton
Zagami, Paola
Nicolo, Eleonora
Trapani, Dario
Boldrini, Laura
Salimbeni, Beatrice Taurelli
Ascione, Liliana
Antonarelli, Gabriele
Corti, Chiara
Esposito, Angela
Criscitiello, Carmen
Fusco, Nicola
Curigliano, Giuseppe
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P1-14-05
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-14-05
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
    Li, Yaqi
    Liang, Lei
    Dai, Weixing
    Cai, Guoxiang
    Xu, Ye
    Li, Xinxiang
    Li, Qingguo
    Cai, Sanjun
    MOLECULAR CANCER, 2016, 15
  • [42] Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
    Yaqi Li
    Lei Liang
    Weixing Dai
    Guoxiang Cai
    Ye Xu
    Xinxiang Li
    Qingguo Li
    Sanjun Cai
    Molecular Cancer, 15
  • [43] Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
    Ahrong Kim
    So Jeong Lee
    Young Keum Kim
    Won Young Park
    Do Youn Park
    Jee Yeon Kim
    Chang Hun Lee
    Gyungyub Gong
    Gi Yeong Huh
    Kyung Un Choi
    Scientific Reports, 7
  • [44] Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
    Kim, Ahrong
    Lee, So Jeong
    Kim, Young Keum
    Park, Won Young
    Park, Do Youn
    Kim, Jee Yeon
    Lee, Chang Hun
    Gong, Gyungyub
    Huh, Gi Yeong
    Choi, Kyung Un
    SCIENTIFIC REPORTS, 2017, 7
  • [45] Expression analysis of programmed cell death 1 ligand 1 (PD-L1) in patients with non-small cell lung cancer
    Peng, Nanqiu
    Qin, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2022, 15 (01): : 1 - 5
  • [46] Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine Differentiation
    von Hardenberg, Jost
    Hartmann, Sarah
    Nitschke, Katja
    Worst, Thomas Stefan
    Ting, Saskia
    Reis, Henning
    Nuhn, Philipp
    Weis, Cleo-Aron
    Erben, Philipp
    CLINICAL GENITOURINARY CANCER, 2019, 17 (02) : 145 - +
  • [47] Tumor cell drug resistance induced by the programmed death ligand 1 (PD-L1) immune checkpoint is associated with autophagy
    Minassian, Lori M.
    MacDonald-Goodfellow, Shannyn K.
    Truesdell, Peter
    Sanwalka, Daniel
    Craig, Andrew W.
    Koti, Madhuri
    Siemens, D. Robert
    Graham, Charles H.
    CANCER RESEARCH, 2017, 77
  • [48] Binding Free Energy Analysis of Programmed Cell Death Protein PD1 to its Ligand PD-L1
    Pan, Peter C.
    Tafazzol, Alireza
    Zhang, Xianwei
    Duan, Yong
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 477A - 477A
  • [49] BINDING FREE ENERGY ANALYSIS OF PROGRAMMED CELL DEATH PROTEIN PD1 TO ITS LIGAND PD-L1
    Pan, Peter
    Tafazzol, Alireza
    Zhang, Xianwei
    Duan, Yong
    NEURO-ONCOLOGY, 2018, 20 : 67 - 67
  • [50] The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor
    Brinch, Charlotte Margareta
    Hogdall, Estrid
    Junker, Niels
    Moeller, Holger Jon
    Sandfeld-Paulsen, Birgitte
    de Heer, Pieter
    Penninga, Luit
    Rossen, Philip Blach
    Krarup-Hansen, Anders
    Aggerholm-Pedersen, Ninna
    CANCERS, 2022, 14 (23)
12345